Results 271 to 280 of about 351,954 (346)
ABSTRACT Introduction Following treatment, relapse of Multiple Myeloma (MM) occurs due to measurable residual disease (MRD). As therapeutic options expand, advances in response assessment become more critical, necessitating more sensitive MRD detection methods.
Aisling O'Brien +2 more
wiley +1 more source
Prognostic and therapeutic implications of disulfidptosis-related genes in multiple myeloma. [PDF]
Zang Y +8 more
europepmc +1 more source
Imaging flow cytometric detection of del(
Thomas I. Mincherton +8 more
openalex +1 more source
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot +3 more
wiley +1 more source
Muscle Fat Infiltration in Patients with Multiple Myeloma: A Case-Control Study. [PDF]
Zhu T, Zhou H, Zhang D, Chen X, Lu X.
europepmc +1 more source
Ubiquitination dynamics in human tumour viruses: Viral infection, oncogenesis and antiviral therapy
The ubiquitin system is essential for cellular homeostasis and regulates many processes. Viruses, including oncogenic ones, exploit or evade this system to survive and replicate. This review explores how human tumour viruses manipulate the ubiquitination system to complete their life cycle, evade immunity and promote cancer.
Oscar Trejo‐Cerro +2 more
wiley +1 more source
Multiple myeloma in a man with breast cancer: A case report and literature review. [PDF]
Zhou X, Li MR, Sui XH, Shan NN.
europepmc +1 more source
A guide to the types, structures, and multifaceted functions of matrix metalloproteinases in cancer
Matrix metalloproteinases (MMPs) orchestrate cancer progression and metastasis through proteolytic and non‐proteolytic actions. By remodeling the tumor microenvironment, enhancing growth factor availability, and modulating cell behavior, MMPs promote proliferation, migration or invasion, and epithelial‐to‐mesenchymal transition. Alongside extracellular
Zoi Piperigkou +4 more
wiley +1 more source
Utilization of real-world evidence in regulatory approvals for multiple myeloma therapies. [PDF]
Taylor L, Chen A, Pierre A.
europepmc +1 more source

